Expedited insurance appeals: when and how to request one

The 72-hour rule

Under the Affordable Care Act and Department of Labor regulations, insurers must decide an expedited internal appeal within 72 hours of receiving a complete request. The same 72-hour window applies to expedited external review under federal external-review rules. Some state programs are slightly faster — New York’s Department of Financial Services, for example, runs an expedited external appeal process with specific consumer protections.

Federal rules require a decision within 72 hours when standard timing could seriously jeopardize your life, health, or ability to regain maximum function.

Clinical situations that qualify

Insurers will often resist expediting unless the clinical urgency is concrete. Situations that consistently qualify include:

• Ongoing inpatient care. A denial that would end coverage of a current hospital stay or force premature discharge.
• Scheduled surgery within roughly 14 days. A prior-authorization denial where rescheduling would mean clinical deterioration, loss of an operating-room slot with a long wait, or interrupted pre-operative protocols.
• Urgent medication continuation. Transplant immunosuppressants, oncology regimens, biologics, certain mental health medications, and specialty drugs where a gap risks serious harm.
• End-of-life or palliative care. Denials affecting hospice coverage, palliative interventions, or symptom-management treatment.
• Severe, untreated pain or rapidly worsening condition. Where waiting weeks would meaningfully degrade function or recoverability.

How to phrase the request

The strongest expedited requests are short, dated, and explicit. They state the medical risk of waiting in clinical terms, attach a treating-provider statement, and ask for both expedited internal appeal and expedited external review where appropriate.

1. Open with the request. “I am requesting an expedited internal appeal under 29 CFR 2560.503-1 and 45 CFR 147.136 because a standard timeline would seriously jeopardize my health.”
2. State the clinical urgency in one or two sentences. Reference the specific risk: missed surgery, interrupted medication, ongoing inpatient stay, etc.
3. Attach a treating-provider letter. A short, dated statement from the prescribing or treating clinician describing the risk of delay. This is the single most important attachment.
4. Request simultaneous expedited external review. Cite your right to file both tracks at once. Include the relevant state external-review program where applicable.
5. Provide contact methods for fast response. Phone, secure portal, and a fax number for the insurer’s answer. 72 hours is short.

How to escalate to expedited external review

For urgent situations you do not have to wait for the internal appeal to finish. Federal external-review rules allow simultaneous expedited filings. Practically, that means filing both packages on the same day:

• The expedited internal appeal goes to the insurer’s appeals unit per the denial letter.
• The expedited external review goes to the entity listed in your denial letter as the external-review contact — the state Department of Insurance for state-run programs, or the federally-administered process where federal rules apply.

For Texas residents, the Texas Department of Insurance runs certified IROs that can be triggered on an expedited basis; see our Texas external review page for details. For an overview of how external review fits into the appeals process generally, see internal appeal vs. external review.

Common reasons expedited requests get denied

Insurers can decline to expedite if they conclude the situation is not urgent. The usual reasons:

• No treating-provider statement. A member urgency claim without clinical backing is weak. Attach a provider note.
• Vague language. “I really need this” doesn’t qualify. Specific clinical risk does.
• The denial is post-service. Some insurers argue that a claim for care already received doesn’t support expedited treatment. The exception is ongoing inpatient care or active treatment cycles where downstream services depend on the appeal outcome.

When time is the whole game

For scheduled surgeries, continuing inpatient stays, and urgent medication denials, the deadline isn’t a detail — it’s the point. If your situation involves a GLP-1, a biologic, or another specialty drug, our pillar on GLP-1 medication denials covers the specific evidence patterns insurers respond to. For the standard (non-expedited) timeline by comparison, see how long does an insurance appeal take.

Start with a free triage See pricing